Table 5 Comparison of the final adjusted means, according to groups allocation
Variables | Usual care control group | Intervention group | ∆ | CI (95%) | p value 1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | MI | CI (95%) | FAM | CI (95%) | n | MI | CI (95%) | FAM | CI (95%) | ||||
Weight (Kg) | 35 | 80.2 | 76.0–84.4 | 81.2 | 80.3–82.0 | 51 | 80.4 | 77.0–83.7 | 79.8 | 79.1–80.5 | −1.4 | −2.5;-0.3 | .01 |
BMI (kg/m2) | 35 | 32.8 | 31.6–34.1 | 33.5 | 33.1–33.8 | 51 | 33.3 | 32.2–34.4 | 33.0 | 32.7–33.3 | −0.5 | −0.9; −0.5 | .03 |
WC (cm) | 35 | 96.8 | 94.4–99.3 | 95.0 | 93.5–96.5 | 51 | 93.3 | 90.1–96.4 | 93.7 | 92.6–94.9 | −1.3 | −3.2; 0.6 | .19 |
Energy consumption (KJ) | 35 | 1404.4 | 1254.2–1554.6 | 1465.4 | 1356.7 | 51 | 1513.2 | 1392.1–1634.3 | 1392.1 | 1302.3–1481.8 | −73.4 | − 216.0; 69.2 | .31 |
Adiponectina (ng/mL) | 15 | 29.7 | 20.1–39.3 | 24.9 | 19.0–30.7 | 20 | 23.9 | 16.4–31.4 | 25.1 | 20.0–30.1 | 0.2 | −7.9;8.3 | .96 |
Resistina (pg/mL) | 15 | 4.8 | 2.1–7.5 | 3.8 | 2.4–5.2 | 20 | 4.8 | 3.6–6.0 | 5.8 | 4.6–7.0 | 2.0 | −0.6; 3.9 | .04 |
Blood glucosea (mg/dl) | 15 | 94.7 | 85.1–104.2 | 94.0 | 87.2–100.8 | 20 | 95.2 | 79.6–110.8 | 81.3 | 75.6–87.1 | −12.6 | −22.0;-3.3 | .10 |